Replies to post #27335 on Enzolytics Inc (ENZC)

[slb5150]

first follow...welcome aboard!

[Truenorth2016]

OMG!!!!: "Essentially, we're looking at "Disruption Technology" in motion here!"


LITERALLY PASSING OUT!!! WE ARE GETTING THE OPPORTUNITY TO BUY THIS AT SUB-PENNY!!! WE ARE INCREDIBLY BLESSED!!! WE TOTALLY CAUGHT WALL STREET OFF GUARD WITH THIS ONE!!! OMG!!!

[tripleDz]

Just got goosebumps reading your post $$$$$

[Truenorth2016]

ENZC STARTING TO PLAY OUT LIKE A BIOTECH MOVIE WITH DR. FAUCI INVOLVED WITH OUR MERGER PARTNER BIOCLONETICS CEO AND NOW ENZC BOARD OF DIRECTORS MR. CHARLES COTROPIA!!!

THIS 2013 INTERNET ARTICLE CONFIRMS THE TWO KNEW EACH OTHER IN 1989-1999 AND BATTLED OVER DR. COTROPIA (ENZC BOARD OF DIRECTORS) EXCLUSIVE U.S PATENT!!! MR. COTROPIA WAS GRANTED THE PATENT BOVER DR. FAUCI AND THE GOVERMENT TOOK DR. COTROPIA SIDE!!! OMG!! THIS IS A MOVIE!!!

https://aumag.org/2013/09/26/the-future-of-clone-3/

"Stranger still—in 1999, the government had made a patent application that overlapped an area covered by Dr. Cotropia’s 1989 patents. The government listed NIAID director Anthony Fauci and others as the “inventors.” In the affidavit required by the filing process, Fauci, et al., declared under oath that the neutralizing technology in question had “utility” and “commercial value.” But the U.S. Patent Examiner threw out the government’s bid to own the key area covering Clone 3. He pointed out that Dr. Cotropia and BioClonetics had a prior claim. (<<<<<<<<<<----U.S Government Gave Our ENZC Boards of Directors Mr. Charles COTROPIA The U.S Patent Over Dr. Fauci....OMG!!!)


So if Clone 3 had “commercial value” according to Fauci himself, why was the discovery viewed by others as lacking “innovation?” Talking heads in the AIDS industry, including Fauci himself, have said that the best way to end the AIDS epidemic is an effective AIDS vaccine. Just recently, Fauci discussed the current effort to intensify conventional drug treatment globally, but wrote in conclusion, “An effective HIV vaccine would get us to an AIDS-free generation faster and, more important, help sustain that accomplishment.” Other antibodies, and other vaccine approaches, have been granted their chance at clinical trials. So far, all have failed to deliver real promise."

[bluebird50]

This is big in my opinion.... the transfer of board members! Never seen that before!!

[jaiguruji7]

Thanks for posting the detailed and very smart and awesome DD, really appreciate it!! This is simply UNBELIEVABLY AWESOME!!!!!!! I am fully invested and will be buying 5 - 10 million shares more on Monday. This is once in a lifetime HUGE BIOTECH OPPORTUNITY, with treatments for both HIV and COVID, that is truly awesome. Trust me there will be a HIUGE BIDDING WAR to BUYOUT this company or merged companies, if not already underway. I will be very surprised if this is not already happening, behind the scenes.

What is your share price prediction, when the merger closing/completion is announced? Also by when as per your estimate we will see the merger closing/completion? You mentioned the merger is already closed/completed. How do you know that?

You said 6 months after merger closing/completion, it will be on NASDAQ, with a share price estimate from $5 - $10 correct?

[bluebird50]

Great DD weekend y’all....!!

[fb454]

Welcome and thank you for sharing your expertise. Looking forward to your next post!

[Jisep]

Thx OTC:) We as a group are happy to have u on board. We would definitely appreciate your expertise in this area now and going forwards. Thx again:)

[suny66]

Welcome ShotCaller. We need your expertise here and thank for sharing.

[BluE33]

There is no competition for BioClonetics & $ENZC HIV scientific research!!!

Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts on a massive surge of volume after the Company announced on Sept 15, 2020 the execution of a non-binding LOI to merge with BioClonetics Immunotherapeutics, Inc. a biotech company located in Dallas Texas. BioClonetics is in the final stage of development of a parent monoclonal antibody (“mAbs”) (designated as Clone 3), which is non-toxic and has shown in initial in-vitro testing to be effective against greater than 95% of all strains of HIV. Nothing like this presently exists!

[DOGONE]

This post should be stickied....tells whats up w this stock.

[God_Father]

Hey OTCShotCaller - I know you joined in hot having done prior DD and a having a solid understanding of what was transpiring. I agreed with everything you said then and still agree with it now. Given where we are today, do you think anything will unfold differently? Also, what company did you work for, was it Merck, Pfizer, etc? Let me know if you want to bounce some thoughts around, I think I know how this is going to play out in the next 2-12 months but want to cross-check with you first.

Thanks bud!

This merger undoubtedly will represent the single greatest thrust in medical science for curing most strains of HIV there by dramatically reducing its impact on humanity rendering it "easily treated" if not cured!

Essentially, we're looking at "Disruption Technology" in motion here!

I have a professional clinical research background that includes bringing pharmaceuticals to market via randomized controlled clinical trials and believe I can make a significant contribution to this message board.

I just joined this forum today and will be posting insightful information from time to time that may help investors in this merger make an informed decision.

I can tell everyone this, I an have done my DD on these two companies and they are BOTH not only the "real deal" but they definitely have what it takes to become THE Global Leader in the space of AIDS/HIV treatment.

I can tell everyone here from experience from being in clinical research most of my professional life,they won't have any problem whatsoever obtaining any amount of funding they need from any and all sources to bring their scientific achievement to commercialization, and by far their stock will quickly transition to either NASDAQ or NYSE with a corresponding dramatic rise in the share price that will likely forward split several times.

My prediction is this stock will move to NASDAQ within 6 months of merger completion which I perceive is already a "done deal" soon to be announced, and when that happens the share price will foreseeably be trading in the $5-$10 range at least a year BEFORE their Phase IV patient trials are complete but with preliminary positive findings. Soon after, the Share Price will soar even higher with anticipated FDA Approval.

Post FDA approval I see this company stock trading easily in the $100-$500 range within 12 months of commercialization IF they are not bought out before then by one of the majors like Merk, Pfizer, etc.

Watch for my posts, I have gathered A LOT of Intel on this Company that includes some very promising numbers! Hint: $7 per share is not an unrealistic near term PPS, but I believe it will be trading on NASDAQ by then.